Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study

OBJECTIVE: A soluble form of suppression of tumorigenicity 2 (sST2) has emerged as a biomarker for acute graft-versus-host disease (GVHD) and non-relapse mortality (NRM). We prospectively monitored sST2 levels during the early phase of hematopoietic stem cell transplantation (HSCT) and evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumura, Ayako, Miyazaki, Takuya, Tachibana, Takayoshi, Ando, Taiki, Koyama, Megumi, Koyama, Satoshi, Ishii, Yoshimi, Takahashi, Hiroyuki, Nakajima, Yuki, Numata, Ayumi, Yamamoto, Wataru, Motohashi, Kenji, Hagihara, Maki, Matsumoto, Kenji, Fujisawa, Shin, Nakajima, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057758/
https://www.ncbi.nlm.nih.gov/pubmed/31464120
http://dx.doi.org/10.4274/tjh.galenos.2019.2019.0139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057758/
https://www.ncbi.nlm.nih.gov/pubmed/31464120
http://dx.doi.org/10.4274/tjh.galenos.2019.2019.0139

Ejemplares similares